|
× |
 |
Return to Life PDF |
$40.00 |
|
$40.00 |
|
× |
|
Insomnia as a Risk for Depression: A Longitudinal Epidemiologic Study on a Japanese Rural Cohort PDF |
$40.00 |
|
$40.00 |
|
× |
|
National Survey of Adherence, Efficacy, and Side Effects of Methylphenidate in Children With Attention-Deficit/Hyperactivity Disorder in Taiwan PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Real-World Assessment of Outcomes in Schizophrenia Patients According to Treatment Response PDF |
$40.00 |
|
$40.00 |
|
× |
|
Mood Stabilizers During Breastfeeding: A Review PDF |
$40.00 |
|
$40.00 |
|
× |
|
Hyperresponsivity to Threat Stimuli in Domestic Violence Offenders: A Functional Magnetic Resonance Imaging Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Effectiveness of Antidepressants in Elderly Depressed Outpatients: A Prospective Case Series Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Sugar Addictive Behavior Resulting From Hypoglycemia Provoked by Insulin Misuse PDF |
$40.00 |
|
$40.00 |
|
× |
|
Screening Physical or Sexual Abuse Victims for Substance Abuse PDF |
$40.00 |
|
$40.00 |
|
× |
|
How Many Subjects With Major Depressive Disorder Meet Eligibility Requirements of an Antidepressant Efficacy Trial? PDF |
$40.00 |
|
$40.00 |
|
× |
|
What Is the Threshold for Symptomatic Response and Remission for Major Depressive Disorder, Panic Disorder, Social Anxiety Disorder, and Generalized Anxiety Disorder? PDF |
$40.00 |
|
$40.00 |
|
× |
|
Relapse Prevention and Residual Symptoms: A Closer Analysis of Placebo-Controlled Continuation Studies With Escitalopram in Major Depressive Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, and Obsessive-Compulsive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Stimulant Formulations for the Treatment of Attention-Deficit/Hyperactivity Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Predictors and Time Course of Response Among Panic Disorder Patients Treated With Cognitive-Behavioral Therapy PDF |
$40.00 |
|
$40.00 |
|
× |
|
Telemental Health Utilization in Commercial Health Insurance Plans in the United States From 2010 Through 2019 PDF |
$40.00 |
|
$40.00 |
|
× |
|
An 8-Week Randomized, Double-Blind Trial Comparing Efficacy, Safety, and Tolerability of 3 Vilazodone Dose-Initiation Strategies Following Switch From SSRIs and SNRIs in Major Depressive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Prevalence of Kratom Use and Co-Occurring Substance Use Disorders in the United States PDF |
$40.00 |
|
$40.00 |
|
× |
|
Elevated Creatine Phosphokinase in a Patient on a Long-Acting Antipsychotic: A Challenging Presentation Similar to Neuroleptic Malignant Syndrome PDF |
$40.00 |
|
$40.00 |
|
× |
|
Establishment of the National Pregnancy Registry for Atypical Antipsychotics PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Case-Controlled Study of Successful Aging in Older HIV-Infected Adults PDF |
$40.00 |
|
$40.00 |
|
× |
|
Clozapine, Diabetes Mellitus, Hyperlipidemia, and Cardiovascular Risks and Mortality: Results of a 10-Year Naturalistic Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Postprandial Oxytocin Secretion Is Associated With Severity of Anxiety and Depressive Symptoms in Anorexia Nervosa PDF |
$40.00 |
|
$40.00 |
|
× |
|
Catatonia After Neuroleptic Malignant Syndrome Successfully Treated With Electroconvulsive Therapy PDF |
$40.00 |
|
$40.00 |
|
× |
|
Satisfaction With Medication Is Correlated With Outcome but Not Persistence in Patients Treated With Placebo, Escitalopram, or Serotonin-Norepinephrine Reuptake Inhibitors: A Post Hoc Analysis PDF |
$40.00 |
|
$40.00 |
|
× |
|
Psychostimulant Use in Schizophrenia for Treatment of Negative Symptoms and Weight Loss PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Review of the Non-Alzheimer Dementias PDF |
$40.00 |
|
$40.00 |
|
|
